Lewy Body Dementias

作者: Zuzana Walker , Katherine L Possin , Bradley F Boeve , Dag Aarsland

DOI: 10.1176/APPI.FOCUS.15105

关键词:

摘要: The broad importance of dementia is undisputed, with Alzheimer’s disease justifiably getting the most attention. However, Lewy bodies and Parkinson’s dementia, now called body dementias, are second common type degenerative in patients older than 65 years. Despite this, dementias receive little attention often misdiagnosed, leading to less ideal management. Over past 10 years, considerable effort has gone into improving diagnostic accuracy by refining criteria using imaging other biomarkers. Dementia share same pathophysiology, effective treatments will depend not only on successful treatment symptoms but also targeting pathological mechanisms disease, ideally before clinical signs develop. We summarise pertinent progress from outlining some challenges for future, which require r...

参考文章(114)
Judy K. Qiang, Yvette C. Wong, Andrew Siderowf, Howard I. Hurtig, Sharon X. Xie, Virginia M.-Y. Lee, John Q. Trojanowski, Dora Yearout, James B. Leverenz, Thomas J. Montine, Matt Stern, Susan Mendick, Danna Jennings, Cyrus Zabetian, Ken Marek, Alice S. Chen-Plotkin, Plasma apolipoprotein A1 as a biomarker for Parkinson disease Annals of Neurology. ,vol. 74, pp. 119- 127 ,(2013) , 10.1002/ANA.23872
He-Jin Lee, Eun-Jin Bae, Seung-Jae Lee, None, Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases Nature Reviews Neurology. ,vol. 10, pp. 92- 98 ,(2014) , 10.1038/NRNEUROL.2013.275
Myria Petrou, Ben A. Dwamena, Bradley R. Foerster, Mark P. MacEachern, Nicolaas I. Bohnen, Martijn LTM Müller, Roger L. Albin, Kirk A. Frey, Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review Movement Disorders. ,vol. 30, pp. 928- 935 ,(2015) , 10.1002/MDS.26191
Miguel Angel Tola-Arribas, María Isabel Yugueros, María José Garea, Fernando Ortega-Valín, Ana Cerón-Fernández, Beatriz Fernández-Malvido, Antonio San José-Gallegos, Marta González-Touya, Ana Botrán-Velicia, Vanessa Iglesias-Rodríguez, Bárbara Díaz-Gómez, Prevalence of Dementia and Subtypes in Valladolid, Northwestern Spain: The DEMINVALL Study PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0077688
Jenny McCleery, Shirlony Morgan, Kevin M Bradley, Anna H Noel-Storr, Olaf Ansorge, Chris Hyde, Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies Cochrane Database of Systematic Reviews. ,vol. 1, ,(2015) , 10.1002/14651858.CD010633.PUB2
Clive Ballard, Zunera Kahn, Anne Corbett, Treatment of Dementia with Lewy Bodies and Parkinson’s Disease Dementia Drugs & Aging. ,vol. 28, pp. 769- 777 ,(2011) , 10.2165/11594110-000000000-00000
Hiroshige Fujishiro, Shinichiro Nakamura, Kiyoshi Sato, Eizo Iseki, Prodromal dementia with Lewy bodies Geriatrics & Gerontology International. ,vol. 15, pp. 817- 826 ,(2015) , 10.1111/GGI.12466
Sonia George, L Rey, Nolwen, Nicole Reichenbach, Jennifer A. Steiner, Patrik Brundin, α‐Synuclein: The Long Distance Runner Brain Pathology. ,vol. 23, pp. 350- 357 ,(2013) , 10.1111/BPA.12046
Michal Rolinski, Chris Fox, Ian Maidment, Rupert McShane, None, Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease Cochrane Database of Systematic Reviews. ,vol. 3, ,(2012) , 10.1002/14651858.CD006504.PUB2